AKT1 and asthma: Although the molecular mechanisms by which OBE produces its anti-inflammatory action are not clear, our data suggests that it likely involves inhibiting the EGFR, ERK1/2 and AKT signaling pathway, which is an important pathway in the asthma phenotype.